Piers C. Whitehead
Directeur Général chez Seromyx Systems, Inc.
Profil
Piers C.
Whitehead is currently the Chief Executive Officer & Director at Seromyx Systems, Inc. Previously, he held the position of Vice President-Corporate & Business Development at VaxGen, Inc. from 2002 to 2008.
He was also the Head-San Francisco at Mercer Management Consulting, Inc. from 1991 to 2002.
Additionally, he served as Vice President-Corporate Development at Neovacs SA and Manager at Robert Fleming Securities Ltd.
Mr. Whitehead received his undergraduate and graduate degrees from the University of Oxford.
Postes actifs de Piers C. Whitehead
| Sociétés | Poste | Début |
|---|---|---|
Seromyx Systems, Inc.
 Seromyx Systems, Inc. Pharmaceuticals: MajorHealth Technology Seromyx Systems, Inc. provides insight into the immune function to discover and develop vaccines, immunotherapies, drugs, and diagnostics. The company was founded by Galit Alter in July 2019 and is headquartered in Cambridge, MA. | Directeur Général | - |
Anciens postes connus de Piers C. Whitehead
| Sociétés | Poste | Fin |
|---|---|---|
VaxGen, Inc.
 VaxGen, Inc. BiotechnologyHealth Technology VaxGen, Inc. is a biopharmaceutical company, owns a state-of-the-art biopharmaceutical manufacturing facility that can be used to make cell culture or microbial biologic products. The company has ended all product development activities and sold or otherwise terminated its drug development programs. It is seeking to maximize the value of its remaining tangible and intangible assets through a transaction or series of transactions, including the sale of the manufacturing facility. The company was founded on November 01, 1995 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 31/08/2008 |
Mercer Management Consulting, Inc.
 Mercer Management Consulting, Inc. Miscellaneous Commercial ServicesCommercial Services Mercer Management Consulting, Inc. provides management consulting services. The company offers business design innovation, brand strategy, operational excellence, transformation, and portfolio strategy services. The firm was founded in 1990 and is located in New York, NY. | Corporate Officer/Principal | 01/01/2002 |
Emergent Travel Health, Inc.
 Emergent Travel Health, Inc. Internet Software/ServicesTechnology Services Emergent Travel Health, Inc. develops vaccines against infectious diseases. The firm develops vaccines against typhoid, cholera, hepatitis, anthrax, and other infectious diseases. Its proprietary adenoviral-based technology platform enables the rapid development of oral vaccines that can target viral or bacterial protein antigen. The company was founded by Kenneth Kelley and Daniel R. Henderson in 2007 and is headquartered in San Diego, CA. | Corporate Officer/Principal | - |
| NEOVACS | Corporate Officer/Principal | - |
| Robert Fleming Securities Ltd. | Corporate Officer/Principal | - |
Formation de Piers C. Whitehead
| University of Oxford | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| NEOVACS | Health Technology |
| Entreprise privées | 5 |
|---|---|
VaxGen, Inc.
VaxGen, Inc. BiotechnologyHealth Technology VaxGen, Inc. is a biopharmaceutical company, owns a state-of-the-art biopharmaceutical manufacturing facility that can be used to make cell culture or microbial biologic products. The company has ended all product development activities and sold or otherwise terminated its drug development programs. It is seeking to maximize the value of its remaining tangible and intangible assets through a transaction or series of transactions, including the sale of the manufacturing facility. The company was founded on November 01, 1995 and is headquartered in South San Francisco, CA. | Health Technology |
Mercer Management Consulting, Inc.
Mercer Management Consulting, Inc. Miscellaneous Commercial ServicesCommercial Services Mercer Management Consulting, Inc. provides management consulting services. The company offers business design innovation, brand strategy, operational excellence, transformation, and portfolio strategy services. The firm was founded in 1990 and is located in New York, NY. | Commercial Services |
| Robert Fleming Securities Ltd. | Finance |
Emergent Travel Health, Inc.
Emergent Travel Health, Inc. Internet Software/ServicesTechnology Services Emergent Travel Health, Inc. develops vaccines against infectious diseases. The firm develops vaccines against typhoid, cholera, hepatitis, anthrax, and other infectious diseases. Its proprietary adenoviral-based technology platform enables the rapid development of oral vaccines that can target viral or bacterial protein antigen. The company was founded by Kenneth Kelley and Daniel R. Henderson in 2007 and is headquartered in San Diego, CA. | Technology Services |
Seromyx Systems, Inc.
Seromyx Systems, Inc. Pharmaceuticals: MajorHealth Technology Seromyx Systems, Inc. provides insight into the immune function to discover and develop vaccines, immunotherapies, drugs, and diagnostics. The company was founded by Galit Alter in July 2019 and is headquartered in Cambridge, MA. | Health Technology |
